Alnylam Pharma (ALNY) Tops Q2 EPS by 15c
Tweet
Share
E-mail
Get Alerts ALNY Hot Sheet
Price: $224.80 +0.09%
Financial Fact:
Unrealized (loss) gain on marketable securities: -18.33M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Unrealized (loss) gain on marketable securities: -18.33M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Alnylam Pharma (NASDAQ: ALNY) reported Q2 EPS of ($1.07), $0.15 better than the analyst estimate of ($1.22). Revenue for the quarter came in at $15.93 million versus the consensus estimate of $22.31 million.
For earnings history and earnings-related data on Alnylam Pharma (ALNY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
- Evogene (EVGN) Tops Q2 EPS by 15c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
